Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from ...

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...

Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others during certain market conditions. Three Motley Fool contr ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Abbott Laboratories ABT has witnessed strong momentum in the past year. Shares of the company have risen 12.7% compared with the 9% growth of the industry during the same time frame. The S&P 500 ...

Global healthcare company Abbott launched the 12th Green Ribbon Action on Friday to advocate for better care of the digestive ...

During this period, the Zacks Medical - Products industry, which Abbott falls in, has lost 1.9%. The key question now is: What could be the stock's future direction? While media releases or rumors ...

Gov. Greg Abbott and Lt. Gov. Dan Patrick may not be seeing eye-to-eye on Patrick's priority push to prohibit all THC products in the Lone Star State. Abbott signaled at a press conference on ...

That morning, Abbott announced that it earned a CE mark in Europe for its Volt PFA System, a product used to treat people with atrial fibrillation (a common heart disorder). PFA stands for pulsed ...